Increased nitric oxide concentrations in the small airway of older normal subjects

Chest

Volumn 139, Issue 2, 2011, Pages 368-375

  Gelb, Arthur F ^a,b   George, Steven C ^c   Camacho, Fernando ^d   Fraser, Christine ^e   Taylor, Colleen Flynn ^e   Shakkottai, Sreelakshmi ^e  

^a Lakewood Regional Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DAMOS Inc   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; NITRIC OXIDE; PULMACORT FLEXHALER; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; AIRWAY; ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); FEMALE; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; LUNG ALVEOLUS; LUNG GAS EXCHANGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 79551575156     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-1157     Document Type: Article

References (44)

1. Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J. 2003;21(3): 433-438. (Pubitemid 36336201)
2. Barnes PJ, Chowdhury B, Kharitonov SA, et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174(1):6-14. (Pubitemid 43955238)
3. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996;153(1):454-457. (Pubitemid 26026889)
4. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;360(9347):1715-1721. (Pubitemid 35447900)
5. Barnes PJ, Dweik R, Gelb AF, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010; 138(3):682-692.
6. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004;84(3):731-765. (Pubitemid 38823765)
7. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest. 2006; 130(5):1541-1546.
8. American Thoracic Society and European Respiratory Society (2005 ATS/ERS). Recommendations for standardized procedure for the online and offl ine measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med. 2005;171(8):912-930.
9. George SC, Hogman M, Permutt S, Silkoff PE. Modeling pulmonary nitric oxide exchange. J Appl Physiol. 2004;96(3): 831-839. (Pubitemid 38248651)
10. Högman M, Holmkvist T, Wegener T, et al. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med. 2002;96(1):24-30. (Pubitemid 41122766)
11. Pietropaoli AP, Perillo IB, Torres A, et al. Simultaneous measurement of nitric oxide production by conducting and alveolar airways of humans. J Appl Physiol. 1999;87(4):1532-1542. (Pubitemid 29483144)
12. Silkoff PE, Sylvester JT, Zamel N, Permutt S. Airway nitric oxide diffusion in asthma:Role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med. 2000; 161(4 Pt 1):1218-1228. (Pubitemid 30243833)
13. Puckett JL, Taylor RW, Leu SY, et al. Clinical patterns in asthma based on a proximal and distal airway nitric oxide categories. Resp Res. 2010;(1):47.
14. Tsoukias NM, Shin HW, Wilson AF, George SC. A single-breath technique with variable fl ow rate to characterize nitric oxide exchange dynamics in the lungs. J Appl Physiol. 2001; 91(1):477-487.
15. Gelb AF, Taylor CF, Nussbaum E, et al. Alveolar and airway sites of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med. 2004;170(7):737-741. (Pubitemid 39298987)
16. Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest. 2006;129(6):1492-1499. (Pubitemid 43894977)
17. Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Inhaled fl uticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J. 2001;18(4): 635-639. (Pubitemid 33040621)
18. van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J. 2006;27(5):951-956. (Pubitemid 44911108)
19. Berry M, Hargadon B, Morgan A, et al. Alveolar nitric oxide in adults with asthma:evidence of distal lung inflammation in refractory asthma. Eur Respir J. 2005;25(6):986-991. (Pubitemid 40823772)
20. Mahut B, Delacourt C, Zerah-Lancner F, De Blic J, Harf A, Delclaux C. Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest. 2004;125(3): 1012-1018. (Pubitemid 38367294)
21. Paraskakis E, Brindicci C, Fleming L, et al. Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med. 2006;174(3):260-267. (Pubitemid 44156604)
22. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest. 2007;131(5):1353-1362. (Pubitemid 46762339)
23. Shin HW, Rose-Gottron CM, Cooper DM, Newcomb RL, George SC. Airway diffusing capacity of nitric oxide and steroid therapy in asthma. J Appl Physiol. 2004;96(1):65-75. (Pubitemid 38031983)
24. Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Bronchial nitric oxide is related to symptom relief during fl uticasone treatment in COPD. Eur Respir J. 2010;35(1):72-78.
25. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J. 2005;26(1):52-59. (Pubitemid 40945931)
26. Roy K, Borrill ZL, Starkey C, et al. Use of different exhaled nitric oxide multiple fl ow rate models in COPD. Eur Respir J. 2007;29(4):651-659. (Pubitemid 46554613)
27. Gelb AF, Flynn Taylor C, Krishnan A, et al. Central and peripheral airway sites of nitric oxide gas exchange in COPD. Chest. 2010;137(3):575-584.
28. Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol. 2007;102(1):417-425. (Pubitemid 46089793)
29. Kerckx Y, Michils A, Van Muylem A. Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients. J Appl Physiol. 2008;104(4):918-924. (Pubitemid 351507926)
30. Kerckx Y, Van Muylem A. Axial distribution heterogeneity of nitric oxide airway production in healthy adults. J Appl Physiol. 2009;106(6):1832-1839.
31. Verbanck S, Kerckx Y, Schuermans D, Vinken W, Paiva M, Van Muylem A. Effect of airways constriction on exhaled nitric oxide. J Appl Physiol. 2008;104(4):925-930. (Pubitemid 351507927)
32. Puckett JL, Taylor RW, Leu SY, et al. An elevated bronchodilator response predicts large airway inflammation in mild asthma. Pediatr Pulmonol. 2010;45(2):174-181.
33. Gelb AF, George SC, Silkoff PE, et al. Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma. Thorax. 2010;65(7):619-625.
34. Olin AC, Bake B, Torén K. Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest. 2007;131(6):1852-1856. (Pubitemid 46981645)
35. Silkoff PE, McClean PA, Slutsky AS, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med. 1997; 155(1):260-267.
36. Hyde RW, Geigel EJ, Olszowka AJ, et al. Determination of production of nitric oxide by lower airways of humans - theory. J Appl Physiol. 1997;82(4):1290-1296. (Pubitemid 27172332)
37. Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Extended exhaled NO measurement differentiates between alveolar and bronchial infl ammation. Am J Respir Crit Care Med. 2001;163(7):1557-1561. (Pubitemid 32578755)
38. Zavorsky GS, Cao J, Murias JM. Reference values of pulmonary diffusing capacity for nitric oxide in an adult population. Nitric Oxide. 2008;18(1):70-79.
39. van der Lee I, Zanen P, Stigter N, van den Bosch JM, Lammers JW. Diffusing capacity for nitric oxide: reference values and dependence on alveolar volume. Respir Med. 2007;101(7): 1579-1584. (Pubitemid 46832217)
40. Aguilaniu B, Maitre J, Glénet S, Gegout-Petit A, Guénard H. European reference equations for CO and NO lung transfer. Eur Respir J. 2008;31(5):1091-1097.
41. Verbanck S, Kerckx Y, Schuermans D, et al. The effect of posture-induced changes in peripheral nitric oxide uptake on exhaled nitric oxide. J Appl Physiol. 2009;106(5): 1494-1498.
42. Gelb AF, Zamel N. Effect of aging on lung mechanics in healthy nonsmokers. Chest. 1975;68(4):538-541.
43. Thomas RA, Green RH, Brightling CE, et al. The infl uence of age on induced sputum differential cell counts in normal subjects. Chest. 2004;126(6):1811-1814.
44. Brindicci C, Kharitonov SA, Ito M, et al. Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(1):21-30.